These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 1349509)
1. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Monroe EW Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919 [TBL] [Abstract][Full Text] [Related]
3. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. Dubertret L; Murrieta Aguttes M; Tonet J J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144 [TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555 [TBL] [Abstract][Full Text] [Related]
6. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis. Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796 [TBL] [Abstract][Full Text] [Related]
7. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria. Salo OP; Harvey SG; Calthrop JG; Gibson JR J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996 [TBL] [Abstract][Full Text] [Related]
8. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria. Sussman G; Jancelewicz Z Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191 [TBL] [Abstract][Full Text] [Related]
9. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385 [TBL] [Abstract][Full Text] [Related]
10. Treatment of pruritus in allergic dermatoses: an evaluation of the relative efficacy of cyproheptadine and hydroxyzine. Baraf CS Curr Ther Res Clin Exp; 1976 Jan; 19(1):32-38. PubMed ID: 812662 [No Abstract] [Full Text] [Related]
11. H1-antihistamines for chronic spontaneous urticaria. Sharma M; Bennett C; Cohen SN; Carter B Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the antipruritic efficacy of hydroxyzine and cyproheptadine in children with atopic dermatitis. Klein GL; Galant SP Ann Allergy; 1980 Mar; 44(3):142-5. PubMed ID: 7362092 [No Abstract] [Full Text] [Related]
13. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Nelson HS; Reynolds R; Mason J Ann Allergy Asthma Immunol; 2000 May; 84(5):517-22. PubMed ID: 10831005 [TBL] [Abstract][Full Text] [Related]
14. Terfenadine in the treatment of chronic idiopathic urticaria and atopic dermatitis. Hjorth N Cutis; 1988 Oct; 42(4A):29-30. PubMed ID: 2903817 [TBL] [Abstract][Full Text] [Related]
15. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis. Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and safety of loratadine syrup in childhood atopic dermatitis treated with mometasone furoate 0.1 per cent cream. Chunharas A; Wisuthsarewong W; Wananukul S; Viravan S J Med Assoc Thai; 2002 Apr; 85(4):482-7. PubMed ID: 12118496 [TBL] [Abstract][Full Text] [Related]
17. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action. Oei HD Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336 [TBL] [Abstract][Full Text] [Related]
19. Treatment of urticaria and angioedema: low-sedating H1-type antihistamines. Soter NA J Am Acad Dermatol; 1991 Jun; 24(6 Pt 2):1084-7. PubMed ID: 1677011 [TBL] [Abstract][Full Text] [Related]
20. Acrivastine versus hydroxyzine in the treatment of cholinergic urticaria. A placebo-controlled study. Kobza Black A; Aboobaker J; Gibson JR; Harvey SG; Marks P Acta Derm Venereol; 1988; 68(6):541-4. PubMed ID: 2467496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]